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ABSTRACT 35 
Objective. Many people with psychotic experiences (PEs) do not develop psychotic 36 
disorders, yet those who seek help demonstrate high clinical complexity and poor outcomes. 37 
In this systematic review and meta-analysis, we evaluated the effectiveness and cost-38 
effectiveness of psychological interventions for people with PEs.  39 
Method. We searched thirteen databases for studies of psychological interventions for adults 40 
with PEs, but not psychotic disorders. Our outcomes were the proportion of participants 41 
remitting from PEs (primary); changes in positive and negative psychotic symptoms, 42 
depression, anxiety, functioning, distress, or quality of life; and economic outcomes 43 
(secondary). We analysed results using multilevel random-effects meta-analysis and narrative 44 
synthesis. 45 
Results. Twenty-seven reports met inclusion criteria. In general, there was no strong 46 
evidence for the superiority of any one intervention. Five studies reported on our primary 47 
outcome, though only two reports provided randomised controlled trial evidence that 48 
psychological intervention (specifically, cognitive behavioural therapy (CBT)) promoted 49 
remission from PEs. For secondary outcomes, we could only meta-analyse trials of CBT. We 50 
found that CBT was more effective than treatment as usual (TAU) for reducing distress 51 
(pooled standardised mean difference: -0.24 [95% CI -0.37 to -0.10]), but no more effective 52 
than the control treatment for improving any other outcome. Individual reports indicated that 53 
CBT, mindfulness-based cognitive therapy, sleep CBT, systemic therapy, cognitive 54 
remediation therapy, and supportive treatments improved at least one clinical or functional 55 
outcome. Four reports included economic evaluations, which suggested CBT may be cost-56 
effective compared with TAU. 57 
Conclusions.  Our meta-analytic findings were primarily null, with the exception that CBT 58 
may reduce the distress associated with PEs. Our analyses were limited by scarcity of studies, 59 
small samples, and variable study quality. Several intervention frameworks showed 60 
preliminary evidence of positive outcomes; however, the paucity of consistent evidence for 61 
clinical and functional improvement highlights a need for further research into psychological 62 
treatments for PEs. 63 
PROSPERO protocol registration number: CRD42016033869 64 
 65 
Keywords: psychosis, ultra-high risk, at-risk mental state, psychotic experiences, 66 
psychological intervention 67 
 68 
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INTRODUCTION 69 
High-risk criteria for psychotic disorders (Yung et al., 2003; Broome et al., 2005; Cannon et 70 
al., 2008; Cornblatt et al., 2002; Miller et al., 2002; Yung et al., 1996) are predicated on the 71 
presence of sub-threshold psychotic symptoms, also called psychotic experiences (PEs), and 72 
the presumption that preventing or delaying transition to a full psychotic disorder syndrome 73 
is a primary therapeutic target. However, most people with PEs never develop a psychotic 74 
disorder (McGorry et al., 2018; Hui et al., 2013; Perez et al., 2017), but have high clinical 75 
complexity, poor response to treatment (Perlis et al., 2011; Valiji Bharmal et al., 2015; 76 
Wigman et al., 2014), sub-optimal clinical and functional outcomes, and increased risk of 77 
self-harm (Fusar-Poli et al., 2012; Granö et al., 2011; Hui et al., 2013; Hutton et al., 2011; 78 
Kelleher et al., 2012; Yates et al., 2019). Despite evidence of these poor outcomes, many 79 
people with PEs do not meet the increasingly high thresholds for secondary care mental 80 
health services, while in primary mental health care settings their PEs often go unnoticed or 81 
untreated even though their depression and anxiety scores are higher, on average, than those 82 
of individuals without PEs (Hui et al., 2013; Perez et al., 2017).  83 
 84 
Research on psychological interventions for people with PEs has mainly focused on delaying 85 
or preventing transition to psychotic disorder. Despite this focus, a recent network meta-86 
analysis of transition rates amongst people at high risk for psychosis found no evidence to 87 
support the effectiveness of needs-based interventions, cognitive behavioural therapy (CBT), 88 
integrated psychological interventions, or family-focused therapy in comparison with each 89 
other (Davies et al., 2018a). A subsequent network meta-analysis of intervention effects 90 
further found that no one specific intervention was more effective than others with regards to 91 
reducing attenuated positive psychotic symptoms (Davies et al., 2018b). Yet, Nelson et al. 92 
(2018) have proposed several limitations of these reviews, citing the omission of (1) trial 93 
evidence demonstrating positive group-level effects of these interventions and (2) key clinical 94 
(e.g. depression and general psychopathology) and functional outcomes that clearly have 95 
important implications for the treatment of people with PEs (Nelson et al., 2018a). 96 
 97 
Recent meta-analyses have left a number of key gaps concerning interventions for people 98 
with PEs that must be filled in order to ensure that treatment decisions and clinical guidelines 99 
are based on the most relevant, accurate, and up-to-date evidence available. First, most 100 
reviews have limited their focus to ‘ultra-high risk’ or ‘clinical high risk’ populations, thereby 101 
omitting people with PEs who may not have these diagnoses. Second, there is presently no 102 
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meta-analytic evidence addressing the question of which psychological interventions lead to 103 
remission from PEs and improvement in depression, anxiety, and general functioning, all of 104 
which are important features of at-risk states for psychosis that lead to disability (Byrne and 105 
Morrison, 2014; Fowler et al., 2018; Law and Morrison, 2014). Third, the psychological 106 
intervention that has been most investigated in the context of people with PEs is CBT, whilst 107 
the evidence concerning alternative approaches has yet to be collated (Nelson et al., 2009). 108 
Fourth, the cost-effectiveness of achieving therapeutic targets other than transition has 109 
received little attention. Fifth, no review has set limitations for the use of antipsychotics, 110 
despite the fact that international guidelines do not generally recommend their use for people 111 
at-risk for developing psychosis (Addington et al., 2017; Early Psychosis Guidelines Writing 112 
Group and EPPIC National Support Program, 2016; National Institute for Health and Care 113 
Excellence, 2014b; Schmidt et al., 2015). Finally, no review has aimed to illuminate the key 114 
ingredients of effective psychological interventions for this population. To address these 115 
significant gaps in the literature and to inform the development of a new therapeutic 116 
framework, we conducted a systematic review and meta-analysis that aimed to (1) synthesise 117 
evidence about the effectiveness of and economic outcomes associated with psychological 118 
interventions for people with PEs, and (2) identify common components of effective 119 
interventions. 120 
 121 
METHODS 122 
This review was conducted as part of the Tailoring evidence-based psychological therapY for 123 
People with common mental disorder including Psychotic EXperiences (TYPPEX), a 124 
nationwide NIHR Programme Grant for Applied Research (RP-PG-0616-20003) that aims to 125 
develop an effective therapeutic framework for service users with PEs in the UK Improving 126 
Access to Psychological Therapies (IAPT) primary mental health care setting 127 
(https://www.england.nhs.uk/mental-health/adults/iapt/). The programme focuses on clinical 128 
and functional outcomes other than transition to psychotic disorder, reflecting the low 129 
transition rate among individuals with PEs accessing primary mental health care services 130 
(Hui et al., 2013; Perez et al., 2017). The therapeutic framework will adhere to current 131 
international guidelines, which recommend psychological therapy – but not antipsychotic 132 
medication – for the treatment of individuals with PEs (National Institute for Health and Care 133 
Excellence, 2014a; Schmidt et al., 2015). 134 
 135 
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The protocol was registered with the International Prospective Register of Systematic 136 
Reviews (PROSPERO; https://www.crd.york.ac.uk/prospero), registration number: 137 
CRD42016033869 (22 May 2018 version), and a full protocol has been published 138 
prospectively elsewhere (Soneson et al., 2019). We follow the PRISMA (Liberati et al., 2009) 139 
reporting guidelines.  140 
 141 
Data sources and searches 142 
Two research assistants (ES & DR) collaborated with medical librarians at the University of 143 
Cambridge to create the search strategy (Appendix A). The strategy combined terms for PEs, 144 
specific psychotic symptoms, and psychological interventions, as well as database-specific 145 
subject headings. We searched MEDLINE, Embase, and Health Management Information 146 
Consortium (HMIC) via Ovid; PsycINFO, Cumulative Index to Nursing and Allied Health 147 
Literature (CINAHL), Education Resources Information Center (ERIC), and EconLit via 148 
EBSCO; British Nursing Index (BNI) via ProQuest; and all Cochrane databases from 1 149 
January 2000 (or the earliest publication date included in the database, if after 2000) to 15 150 
December 2018 (when we ran all searches). We additionally searched the WHO International 151 
Clinical Trials Registry Platform (WHO ICTRP) for relevant trials and Google Scholar, 152 
EThOS, and Open Grey for grey literature and dissertations. We collected additional citations 153 
through hand-searching reference lists of included publications.  154 
 155 
Study selection 156 
We included studies that examined any psychological intervention in adults with PEs but not 157 
psychotic disorders. To be included in our review, studies were required to have used the 158 
presence of PEs as the main study entry criterion. Due to the variety of terms used to 159 
represent PEs, we included populations with the following diagnoses: at-risk mental state, 160 
ultra-high risk/clinical high risk, attenuated psychosis, psychosis-like experiences, unusual 161 
experiences, sub-threshold psychosis, prodromal psychosis, and schizotypal disorders. We 162 
restricted our studies to adults (operationalised as studies in which participants’ mean age 163 
was ≥16 years) to reflect the age of people attending adult mental health services (e.g. UK 164 
IAPT services).  165 
 166 
We included all frameworks of psychological interventions provided their effects were 167 
studied in people with PEs (i.e. interventions did not need to target PEs specifically). We did 168 
not restrict intervention setting (and included online interventions). We excluded studies that 169 
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combined psychological and pharmacological interventions (i.e. where medication was 170 
provided as part of the intervention protocol). For medication prescribed external to the 171 
intervention, we placed no restriction regarding the proportion of participants taking 172 
medication for depressive or anxiety disorders, but included only studies in which less than 173 
25% of participants were prescribed antipsychotic medication. The decision to limit the 174 
proportion of the study population using antipsychotic medication aligns with international 175 
guidelines’ cautions against prescribing antipsychotics for people at high-risk for developing 176 
psychosis (Addington et al., 2017; Early Psychosis Guidelines Writing Group and EPPIC 177 
National Support Program, 2016; National Institute for Health and Care Excellence, 2014b; 178 
Schmidt et al., 2015). This exclusion criterion further ensured the review was relevant to the 179 
UK IAPT setting, where psychological interventions are the only available treatment. 180 
 181 
Our outcomes of interest were (1) the proportion of participants who remitted from PEs 182 
(primary outcome) and (2) changes in depression, anxiety, functioning, distress, quality of 183 
life, or positive/negative psychotic symptoms (secondary outcomes). We placed no restriction 184 
on which tools were used to measure any of these outcomes, so long as they were valid and 185 
reliable. We did not set an a priori inclusion criterion for how to define remission from PEs 186 
(we include in our results how each study defined/measured this outcome). In addition, we 187 
included studies that reported any of the following economic outcomes: resource use, cost, 188 
partial economic evaluations and full economic evaluations, where full economic evaluations 189 
are those that consider both the cost and outcomes of two or more interventions in a 190 
comparative analysis, whilst partial economic evaluations focus only on cost description, 191 
cost-outcome description or comparative cost analysis (Drummond et al., 2015). Outcomes 192 
did not need to be the primary outcome of a study to be included in our review. 193 
 194 
We placed no restriction on study design or comparator. We chose not to limit our review to 195 
controlled trials in order to ensure that newer intervention frameworks (which may be at pilot 196 
or earlier stages) could be represented. 197 
 198 
We reviewed studies published in any language provided they had an English abstract (no 199 
foreign language articles advanced past the title/abstract screening stage). We excluded 200 
reports published before 2000 (when the at-risk mental state became widely adopted), reports 201 
where only an abstract was available, and secondary analyses of data from the same trial (to 202 
avoid including the same data from one individual multiple times within our results).  203 
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 204 
Two reviewers (ES & DR) independently screened titles and abstracts and excluded 205 
obviously irrelevant titles. We then reviewed the full texts of potentially relevant citations 206 
against our inclusion and exclusion criteria. Disagreements were resolved by discussion, with 207 
input from a third reviewer (CK, JP) as necessary.  208 
 209 
Data extraction and quality appraisal 210 
Three reviewers (ES, DR, MH) designed and piloted data extraction sheets. We extracted 211 
information on study/sample characteristics, intervention components and descriptions, data 212 
for outcomes related to our primary or secondary outcomes, and data required for quality 213 
assessment (see protocol for more detail (Soneson et al., 2019)). Where information was not 214 
available, we consulted study protocols and contacted study authors by email. Two reviewers 215 
independently extracted data from a subset of four papers (17%) and one reviewer extracted 216 
the rest. Both reviewers reviewed all quantitative data for each included study.  217 
 218 
We assessed risk of bias using the Effective Public Health Practice Project’s (EPHPP) 219 
Quality Assessment Tool for Quantitative Studies (Armijo‐Olivo et al., 2012) for all reports 220 
and additionally used the Drummond Critical Appraisal of Economic Evaluations Checklist 221 
(Drummond and Jefferson, 1996) for economic reports. Two raters (ES & DR; MH & SB for 222 
economic studies) independently assessed quality, compared ratings, and resolved 223 
disagreements by discussion. 224 
 225 
Data synthesis and analysis 226 
Meta-analysis 227 
We analysed controlled studies through random-effects meta-analysis of standardised mean 228 
differences (SMDs) for our secondary clinical and functional outcomes (we did not have 229 
sufficient reports to perform meta-analysis for our primary outcome; see below). To combine 230 
outcomes from multiple follow-up points within individual reports, we fitted meta-analytic 231 
multilevel random effects models via functions in the metafor package (Viechtbauer, 2010). 232 
A relatively new methodology, multilevel meta-analysis is becoming popular in the literature 233 
(Fernández-Castilla et al., 2019). The model overcomes the possibility of bias of overall 234 
effect by acknowledging that different time-points are not independent and correcting for 235 
this. 236 
 237 
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Ultimately, we conducted seven separate meta-analyses (one for each secondary outcome), 238 
separating each by the framework of the psychological intervention being investigated (as per 239 
protocol (Soneson et al., 2019)). As CBT was the only intervention to be represented in more 240 
than one study, we were not able to conduct meta-analyses for the other intervention 241 
frameworks included in the review.  242 
 243 
We separated results by comparator framework (supportive treatments (ST) vs. treatment as 244 
usual (TAU)). We classified the following interventions as ST: supportive therapy, 245 
supportive counselling, non-directive reflective listening, needs-based intervention, and 246 
needs-focused intervention. The decision to group these interventions was based on 247 
similarities in their purpose and provision. We considered these interventions to have a 248 
common aim, namely, to act as non-specific active comparison groups. They further share 249 
several characteristics (e.g. warm, empathic listening and absence of active therapeutic 250 
techniques). This classification also facilitates comparison with related reviews that used 251 
similar groupings (Davies et al., 2018a; Davies et al., 2018b). In reporting our results, we 252 
provide separate pooled estimates for each comparator framework (i.e. ST and TAU 253 
separately) as well as an estimate for both comparators combined (i.e. ST and TAU 254 
combined). There are clinical and statistical reasons for this decision. First, the difference 255 
between TAU and ST is not well-defined; for example, ‘treatment as usual’ sometimes 256 
consisted of CBT for depression or anxiety. Second, we found no statistical evidence to 257 
indicate any meaningful difference between outcomes for these comparators. As both 258 
interpretations are valid, and to ensure our results can adequately inform clinical practice, we 259 
include both estimates. 260 
 261 
Sensitivity and subgroup analyses 262 
We also conducted sensitivity analyses by including only those reports that received a global 263 
rating of ‘strong’ on the EPHPP tool.  264 
 265 
No controlled clinical trials (CCTs) met inclusion criteria, and so our planned sensitivity 266 
analysis on the impact of CCTs was not possible. We had also intended to conduct subgroup 267 
analyses based on population (clinical vs. non-clinical), but no studies of non-clinical 268 
populations were eligible for inclusion in the meta-analyses. Finally, we had intended to use 269 
sub-group analyses to quantitatively assess four a priori components of interest for cognitive 270 
therapy as previously highlighted in the literature: assessment of problems and goals, 271 
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formulation, homework, and active change strategies (Flach et al., 2015; Morrison and 272 
Barratt, 2009). However, included reports did not meet our pre-specified criteria for sub-273 
group analyses (see protocol for more detail (Soneson et al., 2019)).  274 
 275 
Assessment of heterogeneity and meta-biases 276 
Although we aimed to assess heterogeneity of the meta-analytic results, this was unreliable 277 
due to low numbers of included reports in each meta-analysis (Deeks et al., 2018). We still 278 
report Cochran’s Q for each meta-analysis, but interpretation needs to be cautious. For the 279 
same reason, it was not possible to perform the assessments of bias (e.g. publication bias, 280 
citation bias) specified in our protocol.  281 
 282 
Narrative synthesis 283 
We use narrative synthesis (Popay et al., 2006) to synthesise effectiveness findings and pre-284 
post changes in our outcomes of interest from (1) controlled studies not eligible for inclusion 285 
in the meta-analyses, and (2) uncontrolled studies. We furthermore narratively describe 286 
findings relating to common components of effective therapies. 287 
 288 
Economic analysis 289 
We present economic studies in tables containing study characteristics and results and use a 290 
narrative approach to synthesise findings as a result of the very small number of identified 291 
studies meeting inclusion criteria for the economic component of the review. We further 292 
discuss reports in terms of quality, using the Drummond checklist (Drummond et al., 2015). 293 
 294 
RESULTS 295 
Search results 296 
 297 
***Insert Fig 1 about here*** 298 
Figure 1. PRISMA flowchart (Liberati et al., 2009) 299 
 300 
We identified 27 reports from 21 studies that met inclusion criteria (flowchart in Figure 1; 301 
summary of studies’ characteristics in Table 1; justifications for exclusion after full-text 302 
screening in Appendix B; summary of baseline and outcome data in Appendix C; 303 
intervention components in Appendix D). Of these 27 reports, four reports using data from 304 
two randomised controlled trials (RCTs) included economic components that met our 305 
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inclusion criteria. The interventions had diverse frameworks; while the vast majority of 306 
studies focused on variations on CBT or ST (always as the comparator), one study each 307 
represented strengths and mindfulness-based online social therapy, sleep CBT, mindfulness-308 
based cognitive therapy, family-focused therapy, family psycho-educational intervention, 309 
cognitive remediation, and systemic therapy (each described below). The majority of these 310 
frameworks have been tested in the past five years, suggesting increased interest in new 311 
intervention frameworks for people with PEs.  312 
 313 
CBT. CBT for PEs (and other therapies where CBT is the key component, e.g. integrated 314 
psychological interventions) (Addington et al., 2011; Bechdolf et al., 2005; Bechdolf et al., 315 
2007; Evans et al., 2017; Ising et al., 2016; Ising et al., 2017; Ising et al., 2015; Kommescher 316 
et al., 2016; Matsumoto et al., 2018; McGorry et al., 2017; McGorry et al., 2013; Morrison et 317 
al., 2012; Morrison et al., 2004; Nelson et al., 2018b; Stafford et al., 2015; Stain et al., 2016; 318 
van der Gaag et al., 2012) explore the links between thoughts, emotions, and behaviour. The 319 
therapy is formulation-driven, problem-oriented, time-limited, and tailored to patients’ needs. 320 
The key components include patient engagement, creation of a mutually-agreed problem list, 321 
formulation, normalisation of PEs and patients’ interpretations of them, evaluation of 322 
alternative explanations, and behavioural experiments to challenge patients’ appraisals of 323 
PEs. 324 
 325 
Cognitive remediation. Cognitive remediation refers to behavioural training aimed at 326 
improving cognitive processes (e.g. attention, memory, and executive function) (Barlati et al., 327 
2013). The cognitive remediation intervention included in this review focuses on improving 328 
auditory processing in people with PEs (Piskulic et al., 2015). It is computer-based and 329 
includes several different exercises aimed to improve the diverse aspects of auditory 330 
processing. 331 
 332 
Family-focused therapy. This therapy (O'Brien et al., 2015) treats people with PEs in the 333 
context of the family. The key components include psychoeducation around topics such as 334 
symptoms, daily stressors, coping strategies, the vulnerability-stress perspective, family 335 
support, and prevention action plans. Family members learn a structured approach to defining 336 
problems, breaking down complex problems, brainstorming solutions, analysing pros and 337 
cons of possible solutions, and selecting and implementing action plans. 338 
 339 
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Family psychoeducational intervention. The included family psychoeducational intervention 340 
(O'Brien et al., 2015) was a brief, 3-session process of providing education and information. 341 
The content mirrored that of the psychoeducation aspect of the family-focused therapy 342 
described above. 343 
 344 
Mindfulness-based cognitive therapy (MBCT). Mindfulness-based cognitive therapy 345 
(Langer et al., 2010)  includes psychoeducation and exercises to demonstrate the links 346 
between thinking and feeling. Specific techniques include ‘Body Scan’ training, mindful 347 
breathing, breathing space, yoga, and sitting meditation. The intervention uses a group-based 348 
format.  349 
 350 
Sleep CBT. The sleep CBT included this review (Bradley et al., 2017) used the ‘SleepWell’ 351 
treatment package, which utilises CBT techniques to address insomnia and circadian rhythm 352 
disruption to reduce sleep disturbances. Therapists use individualised formulation of sleep 353 
problems to identify treatment targets and actigraphy data to monitor changes in sleep 354 
patterns and highlight potential areas for change.  355 
 356 
Strengths and mindfulness-based online social therapy. This intervention, set within a 357 
social media context, takes a strengths and mindfulness-based focus, and uses a self-358 
determination theory of motivation to foster self-efficacy and increase positive emotions 359 
(Alvarez-Jimenez et al., 2018). The intervention provides social ‘online’ support moderated 360 
by expert and peer moderators. Modules addressed personal strengths, mindfulness, 361 
connecting with others, and group problem-solving to promote self-efficacy and interpersonal 362 
problem-solving. 363 
 364 
Systemic therapy. Systemic therapy (Shi et al., 2017) is centred around systemic-365 
constructivist and psychosocial resilience theories. The therapy focuses on solutions and 366 
resources, and encourages patients to reframe their problems and better understand their 367 
available resources in order to solve these problems.  368 
 369 
Supportive treatments. As stated above, the category of supportive treatments includes 370 
supportive therapy, supportive counselling, non-directive reflective listening, needs-based 371 
intervention, and needs-focused intervention (Addington et al., 2011; Bechdolf et al., 2007; 372 
Kommescher et al., 2016; McGorry et al., 2013; Stain et al., 2016; Shi et al., 2017; Phillips et 373 
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al., 2007; Ruhrmann et al., 2007). In general, these interventions are use general counselling 374 
techniques, including warm, empathic, and non-judgmental face-to-face contact and 375 
supportive listening. They do not include active therapeutic techniques.  376 
 377 
***Insert Table 1 about here*** 378 
Table 1. Summary of studies included in the clinical effectiveness component of the review 379 
 380 
The quality of included studies was mixed (Table 2); 21 of the 27 reports used a randomised 381 
controlled trial (RCT) design, of which only four received a global rating of ‘strong,’ ten 382 
received a global rating of ‘moderate,’ and seven received a global rating of ‘weak.’ Selection 383 
bias, confounding, and drop-out were the categories that most limited the global ratings (it 384 
should be noted that a rating of ‘strong’ in the selection bias category is not achievable when 385 
only help-seeking patients are included. Importantly, no study was excluded in the sensitivity 386 
analyses based solely on studying a help-seeking population). The remaining four studies 387 
used a pre-post design – relatively, a much weaker study design – but none of these received 388 
a ‘weak’ rating in any of the applicable categories.  389 
 390 
***Insert Table 2 about here*** 391 
Table 2. Quality of included studies (EPHPP rating tool) 392 
 393 
Primary outcome 394 
Five reports from four studies provided the proportion of participants that remitted from PEs 395 
following psychological intervention (Ising et al., 2016; Matsumoto et al., 2018; Ruhrmann et 396 
al., 2007; Shi et al., 2017; van der Gaag et al., 2012). Meta-analysis was not possible for the 397 
primary outcome: only two reports had the same intervention framework and comparator 398 
category, and the more recent was a follow-up of the first (van der Gaag et al., 2012; Ising et 399 
al., 2016). 400 
 401 
CBT. Both studies of CBT used the CAARMS (Yung et al., 2005) to determine remission 402 
status. In an RCT examining differences between CBT + TAU versus TAU, 70.4% of 403 
participants receiving CBT + TAU had remitted from at-risk mental state (ARMS) status by 404 
12 months post-intervention, as compared with 57.0% of participants receiving TAU only 405 
(p=0.039) (van der Gaag et al., 2012). The difference remained significant at medium-term 406 
follow-up (approximately 3.5 years post-therapy), with 76.3% of CBT + TAU group versus 407 
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58.7% of TAU only in remission (p=0.04) (Ising et al., 2016). A pre-post study of CBT found 408 
ARMS remission rates of 46.2% at post-intervention and 84.6% 6 months post-intervention 409 
(Matsumoto et al., 2018). 410 
 411 
Other frameworks. An RCT comparing systemic therapy with supportive therapy found 412 
greater remission from clinical high risk status (measured using the Scale of Prodromal 413 
Symptoms (Miller et al., 2003)) among those receiving systemic therapy (61.5% versus 414 
46.2%), but the difference was not significant (p=0.431) (Shi et al., 2017). Finally, a trial of a 415 
needs-focused intervention found a 20.5% remission rate from all psychotic symptoms 416 
(assessed with the Early Recognition Inventory – Positive Psychosis Spectrum (ERI-PPS) 417 
(Klosterkötter et al., 2001)) at post-therapy (Ruhrmann et al., 2007). 418 
 419 
Secondary outcomes 420 
As mentioned above, we were only able to include studies of CBT in our meta-analyses, as 421 
CBT was the only framework examined in two or more studies. 422 
 423 
***Insert Figure 2 about here*** 424 
Figure 2. Positive psychotic symptoms: meta-analysis summary plot (NB: follow-up times are measured from 425 
the end of the intervention). CBT: cognitive behavioural therapy; TAU: treatment as usual; ST: supportive 426 
treatments. 427 
 428 
***Insert Figure 3 about here*** 429 
Figure 3. Negative psychotic symptoms: meta-analysis summary plot (NB: follow-up times are measured from 430 
the end of the intervention). CBT: cognitive behavioural therapy; TAU: treatment as usual; ST: supportive 431 
treatments. 432 
 433 
***Insert Figure 4 about here*** 434 
Figure 4. Distress: meta-analysis summary plot (NB: follow-up times are measured from the end of the 435 
intervention). CBT: cognitive behavioural therapy; TAU: treatment as usual; ST: supportive treatments. 436 
 437 
***Insert Figure 5 about here*** 438 
Figure 5. Depression: meta-analysis summary plot (NB: follow-up times are measured from the end of the 439 
intervention). CBT: cognitive behavioural therapy; TAU: treatment as usual; ST: supportive treatments. 440 
 441 
***Insert Figure 6 about here*** 442 
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Figure 6. Anxiety: meta-analysis summary plot (NB: follow-up times are measured from the end of the 443 
intervention). CBT: cognitive behavioural therapy; TAU: treatment as usual; ST: supportive treatments. 444 
 445 
***Insert Figure 7 about here*** 446 
Figure 7. Functioning: meta-analysis summary plot (NB: follow-up times are measured from the end of the 447 
intervention). CBT: cognitive behavioural therapy; TAU: treatment as usual; ST: supportive treatments. 448 
 449 
***Insert Figure 8 about here*** 450 
Figure 8. Quality of life: meta-analysis summary plot (NB: follow-up times are measured from the end of the 451 
intervention). CBT: cognitive behavioural therapy; TAU: treatment as usual; ST: supportive treatments. 452 
 453 
CBT. We included eight reports from seven studies in our meta-analyses (Figures 2-8), four 454 
of which compared CBT (with or without TAU) with TAU only. CBT was superior to TAU 455 
in reducing distress (pooled SMD = -0.24 favouring CBT [95% CI -0.37 to -0.10]). No other 456 
statistically significant differences were found for positive psychotic symptoms (pooled SMD 457 
= -0.14 favouring CBT [-0.32 to 0.04]), depression (pooled SMD = -0.15 favouring CBT [-458 
0.35 to 0.06]), anxiety (pooled SMD = -0.02 favouring CBT [-0.22 to 0.18]), functioning 459 
(pooled SMD = -0.09 favouring TAU [-0.22 to 0.04]), or quality of life (pooled SMD = -0.03 460 
favouring TAU [-0.24 to 0.18]).  461 
 462 
Four additional reports compared CBT with a supportive treatment (ST; e.g. supportive 463 
therapy, supportive counselling, or non-directive reflective listening). No statistically 464 
significant differences were found for positive psychotic symptoms (pooled SMD = -0.12 465 
favouring CBT [-0.61 to 0.38]), negative psychotic symptoms (pooled SMD = 0.14 favouring 466 
ST [-0.30 to 0.57]), depression (pooled SMD = 0.09 favouring ST [-0.33 to 0.52]), anxiety 467 
(pooled SMD = -0.18 favouring CBT [-0.71 to 0.34]), or functioning (pooled SMD = -0.15 468 
favouring CBT [-0.29 to 0.59]). 469 
 470 
To determine whether there was a difference between the two different control groups, we 471 
included TAU and ST as predictors of SMD in a meta-regression model. Because there was 472 
not a statistically significant difference between the different control groups for any outcome, 473 
we also computed a pooled estimate for all reports regardless of comparator. When TAU and 474 
ST were collapsed into a single comparator group, CBT remained more effective than the 475 
combined TAU/ST comparison groups at reducing distress (pooled SMD: -0.23 favouring 476 
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CBT [-0.36 to -0.10]). There were no other statistically significant differences between CBT 477 
and controls.  478 
 479 
Two reports found significant between-group differences in severity of psychotic symptoms 480 
in two distinct trials, in each instance favouring cognitive therapy (p=0.049 and p=0.018, 481 
respectively) (Morrison et al., 2012; Morrison et al., 2004). A further two reports found 482 
significant between-group differences in distress, but in opposite directions: while one found 483 
lower distress amongst participants in the CBT group (p=0.012) (van der Gaag et al., 2012), 484 
the other found lower distress amongst participants in the non-directive reflective listening 485 
(ST) group (p=0.029) (Stain et al., 2016). No RCT found any statistically significant 486 
between-group differences for depression, anxiety, functioning, or quality of life. 487 
 488 
Additionally, reports from three controlled (Addington et al., 2011; Bechdolf et al., 2007; 489 
McGorry et al., 2017) and four uncontrolled studies (Bechdolf et al., 2005; Evans et al., 2017; 490 
Matsumoto et al., 2018; Stafford et al., 2015) provided results of significance tests for within-491 
group pre-post changes for individuals receiving CBT (several more noted symptom 492 
improvement, but did not provide formal significance testing results). The three reports 493 
providing data on positive psychotic symptoms (Addington et al., 2011; Matsumoto et al., 494 
2018; Stafford et al., 2015), and one of three providing data on negative psychotic symptoms 495 
(McGorry et al., 2017) found significant improvement. Significant improvement was also 496 
noted in four of five reports providing data on depression (Bechdolf et al., 2005; Evans et al., 497 
2017; Matsumoto et al., 2018; McGorry et al., 2017) and functioning (Bechdolf et al., 2005; 498 
Bechdolf et al., 2007; Matsumoto et al., 2018; McGorry et al., 2017), all four reports 499 
providing data on  anxiety (Addington et al., 2011; Bechdolf et al., 2005; Evans et al., 2017; 500 
Matsumoto et al., 2018), one of two providing data on distress (Evans et al., 2017), and in the 501 
one report that provided data on quality of life (Matsumoto et al., 2018). No study found 502 
statistically significant decline in any domain. 503 
 504 
Supportive treatments. Reports from five controlled studies (Addington et al., 2011; 505 
Bechdolf et al., 2007; Phillips et al., 2007; Ruhrmann et al., 2007; Shi et al., 2017) provided 506 
results from significance testing for within-group pre-post changes for individuals receiving 507 
supportive or needs-focused treatments. Two of four reports providing data on positive 508 
psychotic symptoms (Addington et al., 2011; Ruhrmann et al., 2007), but none of the four 509 
providing data on negative psychotic symptoms found significant improvement. Significant 510 
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improvement was noted in two of four reports providing data on depression (Addington et al., 511 
2011; Ruhrmann et al., 2007), one of two providing data on anxiety (Addington et al., 2011), 512 
one of five providing data on functioning (Bechdolf et al., 2007), and in the one report 513 
providing data on in quality of life (Phillips et al., 2007). No study found statistically 514 
significant decline in any domain. 515 
 516 
Other intervention frameworks. Four additional RCTs focused on the systemic therapy (Shi 517 
et al., 2017), mindfulness-based cognitive therapy (MBCT) (Langer et al., 2010), family-518 
focused therapy (FFT) (O'Brien et al., 2015), and cognitive remediation therapy (CRT) 519 
(Piskulic et al., 2015). Only the MBCT trial showed any between-group differences in our 520 
outcomes of interest. In this study, MBCT was more effective than the control condition (a 521 
video viewing forum) at reducing anxiety from baseline to post-therapy (d=0.88, p=0.012) as 522 
well as baseline to 12-week follow-up (d=0.91, p=0.048). However, we found no other 523 
significant between-group differences for psychotic symptoms or distress (Langer et al., 524 
2010). 525 
 526 
Systemic therapy, CRT, and FFT were no more effective than their control treatments 527 
(supportive therapy, computer games, and family psychoeducation, respectively) (Shi et al., 528 
2017; Piskulic et al., 2015; O'Brien et al., 2015). Although neither systemic therapy nor CRT 529 
was more effective than its control treatment, each showed within-group pre-post effects. 530 
Individuals who received systemic therapy showed significant reductions in positive 531 
symptoms (d=0.53, p=0.005) and depressive symptoms (d=0.75, p=0.010) from baseline to 532 
post-therapy, while no such changes were found for the supportive therapy group.(Shi et al., 533 
2017) Similarly, individuals assigned to CRT had significant improvements in social 534 
functioning (p<0.05) from baseline to 6 months post-intervention, while those assigned to the 535 
computer games condition had no significant improvements (Piskulic et al., 2015). 536 
A further two uncontrolled studies examined within-group pre-post effects of a strengths and 537 
mindfulness-based online social therapy (Alvarez-Jimenez et al., 2018) and a CBT 538 
intervention for sleep problems (Bradley et al., 2017). The former found significant 539 
improvements in social functioning (d=1.83, p<0.001) from baseline to post-intervention 540 
(Alvarez-Jimenez et al., 2018), and the latter found significant improvements in depression 541 
and quality of life (p<0.05; exact values not given). These improvements were maintained at 542 
1-month post-therapy, at which time improvement in paranoia and hallucinations also 543 
reached significance (p<0.05; exact values not given) (Bradley et al., 2017). 544 
 17 
Most of the meta-analyses described in this section suffered from high heterogeneity 545 
(Cochran’s Q p<0.05). However, this measure is unreliable when the number of studies 546 
included is very low, so although heterogeneity cannot be discarded, it is hard to ascertain its 547 
extent. 548 
 549 
Sub-group analyses  550 
For sub-group analyses by quality, we were only able to perform two meta-analyses (for 551 
functioning and positive symptoms) due to the fact that in all other meta-analyses there was 552 
only one study without a high risk of bias in at least one category. We found no statistically 553 
significant difference between CBT and TAU in either subgroup analysis (see Appendix E).  554 
 555 
Components of effective interventions 556 
We focused our components analysis on the five interventions that showed effectiveness for 557 
at least one outcome in controlled trials: three CBT (Morrison et al., 2012; Morrison et al., 558 
2004; van der Gaag et al., 2012), one mindfulness-based cognitive therapy (Langer et al., 559 
2010), and one non-directive reflective listening intervention (Stain et al., 2016) (intervention 560 
components in Appendix D). Qualitative examination of the components of these five 561 
therapies revealed high heterogeneity: very few components were shared across the effective 562 
therapies, which is unsurprising given their differing frameworks. Furthermore, there were no 563 
‘key ingredients’ that were particular to these five therapies: although there were some 564 
common components across the effective therapies (e.g. mode of delivery), these were also 565 
shared by therapies that did not demonstrate effectiveness.  566 
 567 
Economic studies 568 
Four reports met inclusion criteria for the economic component of the review (summary of 569 
studies’ characteristics in Appendix F; quality assessment in Appendix G; full economic 570 
analysis in Appendix H). Two focused on CBT (Ising et al., 2017; Ising et al., 2015) and two 571 
on ST (Phillips et al., 2009; Phillips et al., 2007). 572 
 573 
CBT. Ising and colleagues reported the results of full economic evaluations in two reports 574 
(Ising et al., 2017; Ising et al., 2015), which were based on 18-month and 4-year post-575 
baseline data, respectively, from a study conducted in the Netherlands between 2008 to 2010 576 
comparing routine care plus CBT for the prevention of psychosis with routine care alone for 577 
individuals at ultra-high risk of psychosis aged 14 to 35 years old (Rietdijk et al., 2010). At 578 
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18-months post-baseline, the authors concluded that CBT proved to be cost-saving, however, 579 
differences in costs between groups were not tested statistically. When combined with 580 
outcome data, there was some evidence to suggest that CBT plus routine care may be cost-581 
effective compared to routine care alone, but differences were small and no assessment of 582 
uncertainty was carried out. Results were clearer at 4-years post-baseline, with evidence to 583 
suggest a high probability (>80%) of the CBT group being cost-effective compared to routine 584 
care alone. 585 
 586 
Supportive treatments. Phillips and colleagues (Phillips et al., 2009; Phillips et al., 2007) 587 
explored resource use and cost-savings in two reports, both based on data from an RCT 588 
conducted in Australia between 1996 and 1999 which compared a needs-based intervention 589 
(NBI) with NBI plus a specific preventive intervention (SPI) including psychotherapy and 590 
neuroleptic medication for individuals aged 14 to 30 at ultra-high risk of developing 591 
psychotic disorder (McGorry et al., 2002). In the first paper (Phillips et al., 2007), the authors 592 
explored resource use from a mental health service perspective between 12 and 36 months 593 
post-randomisation. Resource use was reported by group for some resource items and by 594 
those who did or did not develop psychosis for others. There was little difference in resource 595 
use with the exception of significantly higher mental health service use for those who did not 596 
develop psychosis in the control arm. However, sample sizes were small (total n=41) and cost 597 
differences were not tested statistically. In the second paper,(Phillips et al., 2009) a cost-598 
savings analysis was undertaken for the full 36-month post-baseline follow-up period. There 599 
were no significant differences in total cost between the groups over the full follow-up. In 600 
terms of outcomes (Phillips et al., 2007), no differences in transition to psychosis rates, level 601 
of symptomatology, or functioning between the groups were identified, therefore indicating 602 
there may be no cost-effectiveness advantage of the intervention. 603 
 604 
DISCUSSION 605 
This systematic review and meta-analysis included 27 reports concerning 21 studies of 606 
psychological interventions for PEs and aimed to determine their effectiveness and cost-607 
effectiveness for improving a range of clinical and functional outcomes. In terms of the 608 
proportion of participants remitting from PEs, we found preliminary evidence from one RCT 609 
and one uncontrolled study for the potential effectiveness of CBT. We did not find meta-610 
analytic evidence that CBT improved PEs on a continuous scale, though it is likely that our 611 
analyses were underpowered to detect small effects. Whilst two individual RCTs favoured 612 
 19 
CBT over TAU for reducing the severity of psychotic symptoms, this effect was not 613 
consistent across all controlled studies. CBT, sleep CBT, and systemic therapy – but not 614 
supportive treatments – also showed promise in terms of within-group pre-post improvements 615 
in psychotic symptoms.  616 
 617 
For our other non-psychotic secondary outcomes (depression, anxiety, functioning, distress, 618 
and quality of life), only the meta-analysis of distress outcomes revealed evidence of 619 
comparative effectiveness, by which CBT was more effective than comparators. However, a 620 
high degree of heterogeneity cannot be discarded in this meta-analysis, meaning that CBT 621 
may not reduce distress in all implementation scenarios in this patient population. Two 622 
individual trials showed a significant effect on distress, but in opposite directions. The only 623 
other RCT evidence of effectiveness was for mindfulness CBT, which significantly reduced 624 
participants’ anxiety symptoms. Low quality evidence from uncontrolled studies showed that 625 
a number of therapies were effective for at least one non-psychotic clinical or functional 626 
outcome, including CBT, sleep CBT, systemic therapy, CRT, and mindfulness online social 627 
therapy. Supportive treatments were fairly effective at improving anxiety and depression, but 628 
not other outcomes.  629 
 630 
The overall quality of studies included in the effectiveness component of the review was 631 
variable. Whilst most reports (21 of 27) focused on data from RCTs (the gold standard study 632 
design for investigating intervention effect), all but four of these received a rating indicating 633 
high risk of bias in at least one of the rating categories. High rates attrition were the 634 
predominant reason for lower ratings, followed by high chance of selection bias. The six non-635 
randomised, uncontrolled studies, although prone to the significant biases associated with 636 
lower quality study design, did not receive any rating indicating high risk of bias in any other 637 
applicable category (these were not rated in terms of blinding or confounders). 638 
 639 
Economic data meeting the inclusion criteria were only identified in four publications, which 640 
used data from two RCTs, one focusing on CBT and the other focusing on a specific 641 
preventive intervention which included psychotherapy and antipsychotic medication. Both 642 
interventions were targeted at young adults at ultra-high risk of psychosis. No economic data 643 
were identified for any other interventions. The included economic studies were 644 
methodologically strong, meeting most of the Drummond checklist quality assessment 645 
criteria (Drummond and Jefferson, 1996). The economic studies focusing on CBT indicate 646 
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that the addition of CBT to routine care has a high probability of being cost-effective 647 
compared to routine care alone in this ultra-high risk group. 648 
 649 
Several previous systematic reviews and meta-analyses have examined the effectiveness of 650 
psychological, pharmacological, and nutritional interventions for people with PEs. Although 651 
most reviews focused primarily on transition (and four focused exclusively on transition), 652 
seven (Davies et al., 2018b; Hutton and Taylor, 2014; Marshall and Rathbone, 2011; 653 
Okuzawa et al., 2014; Stafford et al., 2013; van der Gaag et al., 2013; Devoe et al., 2019) also 654 
reported selected secondary outcomes that do correspond with the current review’s focus, 655 
specifically psychotic symptoms (Davies et al., 2018b; Marshall and Rathbone, 2011; 656 
Okuzawa et al., 2014; Stafford et al., 2013; Devoe et al., 2019), distress (Hutton and Taylor, 657 
2014; Okuzawa et al., 2014), depression (Marshall and Rathbone, 2011; Okuzawa et al., 658 
2014; Stafford et al., 2013), anxiety (Marshall and Rathbone, 2011; Okuzawa et al., 2014), 659 
functioning (Hutton and Taylor, 2014; Marshall and Rathbone, 2011; Okuzawa et al., 2014; 660 
van der Gaag et al., 2013), and quality of life (Hutton and Taylor, 2014; Marshall and 661 
Rathbone, 2011; Okuzawa et al., 2014; Stafford et al., 2013). Importantly, no prior review 662 
has included a consideration of remission from PEs. None of these reviews (including the 663 
review upon which current UK clinical guidelines are based) has found strong evidence to 664 
support the effectiveness of any particular psychological intervention for improving our 665 
outcomes of interest within this population. In general, these reviews reflect our own results. 666 
However, departing from previous findings, we found meta-analytic evidence that distress 667 
was significantly reduced after CBT compared with control treatments (TAU/ST). It is 668 
possible that distress is a significant, under-measured, and under-reported outcome in the 669 
literature; indeed, only two previous reviews have reported distress as an outcome. Distress is 670 
an important factor to individuals with PEs as reductions can be interpreted as improvement, 671 
despite residual symptoms (Byrne and Morrison, 2014; Fowler et al., 2018; Law and 672 
Morrison, 2014); consequently, a broader consideration of this outcome is warranted. 673 
Major treatment guidelines currently recommend CBT for the treatment of people at-risk for 674 
developing psychosis (Addington et al., 2017; Early Psychosis Guidelines Writing Group and 675 
EPPIC National Support Program, 2016; National Institute for Health and Care Excellence, 676 
2014b; Schmidt et al., 2015). In the UK, the National Institute for Health and Care 677 
Excellence (NICE) highlights the value of CBT for preventing transition to frank psychotic 678 
disorder (National Institute for Health and Care Excellence, 2014a). However, recent meta-679 
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analytic evidence published since the creation of these guidelines suggests that CBT for 680 
populations at-risk for developing psychosis may not be superior to other inventions in 681 
preventing transition (Davies et al., 2018a), although it is important to note that concerns 682 
have been raised about both the methodology and interpretation of results in this review 683 
(Nelson et al., 2018a). Our findings provide initial evidence that, whilst doubts remain about 684 
its effectiveness in terms of preventing transition to psychosis, CBT may nevertheless be 685 
more effective than other approaches at promoting remission from PEs and reduction of 686 
associated distress, and thus may still be considered as a potentially useful intervention for 687 
treating people with PEs. Conversely, when the aim of psychological intervention is to reduce 688 
other clinical symptoms (e.g. depression and anxiety) or functional impairment associated 689 
with PEs, CBT falls short in demonstrating effectiveness as compared with other treatments. 690 
This is an important shortcoming, as poor clinical and functional outcomes may serve to 691 
perpetuate mental ill health that may still require more than just monitoring for changes in 692 
post-CBT persistent symptoms, as currently recommended by NICE (National Institute for 693 
Health and Care Excellence, 2014a). 694 
 695 
Strengths and Limitations  696 
This review has a number of important strengths and addresses key gaps in the literature 697 
concerning psychological interventions for people with PEs. Specifically, to our knowledge, 698 
we were the first to meta-analyse studies across such a broad range of clinical and functional 699 
outcomes. Second, we focus on remission from PEs, a new and important outcome that was 700 
developed in collaboration with our lived experience advisory panel. Third, we include 701 
economic outcomes, which again have not been reviewed previously. Fourth, we review a 702 
large number of studies not included in any other review, including, importantly, studies of 703 
newer, non-CBT frameworks 704 
 705 
These strengths notwithstanding, our review, and in particular our meta-analyses, has a 706 
number of limitations. First, each meta-analysis included a small number of reports, each of 707 
which had a limited number of participants (sometimes short of the recruitment target). This 708 
will have reduced our power to detect small, but potentially clinically meaningful, treatment 709 
effects. We aimed to increase power by including multiple study follow-up points within each 710 
meta-analysis. Although we could also have combined outcomes to reduce the total number 711 
of meta-analyses (and also the probability of type I error), we chose not to do this as (1) 712 
sometimes outcomes changed in different directions following intervention (for an example, 713 
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see Langer et al. (2010)), and (2) Cochrane warns against combining heterogeneous 714 
outcomes (see Section 9.1.4) (Higgins and Green, 2011). Second, the high number of meta-715 
analyses performed will have increased the probability of false positive results, which is 716 
particularly important in our analyses due to the fact that we found only one significant 717 
effect. Third, we could not rule out high heterogeneity within our meta-analyses. Fourth, our 718 
decision to group several therapy types under ‘supportive therapy’ was not without 719 
limitations; for example, patients under TAU conditions may well receive CBT for other 720 
mental health problems outside of PEs (e.g. depression or anxiety). Fifth, our exclusion 721 
criteria regarding age range and antipsychotic use may limit the generalisability of our 722 
findings to younger populations or patients prescribed antipsychotic medication as part of 723 
their treatment plan. Sixth, in terms of the studies themselves, whilst many utilised 724 
randomised controlled designs, the overall methodological quality was not high; only four 725 
studies received a global rating of ‘high’ on the quality rating tool. Finally, we acknowledge 726 
that we were not able to fulfill all a priori review aims. Whilst the review was ambitious, we 727 
contend that it was not possible to predict which aims could and could not be accomplished. 728 
Furthermore, we believe that highlighting gaps in the literature is an important step in moving 729 
the field forward. 730 
 731 
Conclusions 732 
This review has clear clinical relevance and will be central in the development of a new 733 
therapeutic framework for IAPT, as well as for other programmes aiming to address PEs in 734 
primary mental health care settings internationally. The broad aims, comprehensive 735 
outcomes, and specific selection criteria all reflect this purpose. The review will ensure any 736 
decisions concerning treatment development and treatment selection for people with PEs 737 
within primary care are supported by the most recent and high-quality evidence. Overall, our 738 
findings indicate that clinicians must consider a wider range of clinical and functional 739 
outcomes as well as interventions for people with PEs that go beyond strategies for 740 
preventing transition to psychotic disorders. Our systematic review and meta-analysis suggest 741 
that, despite its limited effectiveness in preventing transitions, CBT may be useful to reduce 742 
the distress associated with PEs and cost-effective in comparison with treatment as usual. 743 
However, the scarcity of studies focusing on remission from PEs and improvement of other 744 
non-psychotic clinical and functional outcomes suggests a need for further research into 745 
psychological treatments for this population. 746 
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